Trametinib is a MEK inhibitor, mainly used for treating BRAF V600E/K-mutant melanoma and NSCLC. Its job is to stop MEK signaling. You should take it at 2 mg every day, best on an empty stomach.
It’s available in two doses – 0.5 mg and 2 mg, both as coated pills. You get 30 tablets per bottle, for each dose. It’s meant to help control cancer’s spread in people with certain BRAF gene mutations.
The active ingredient Trametinib is the key constituent that targets the RAFL (Raf-like) family proteins, thereby interrupting the RAS-MAPK signaling cascade, which is associated with cell proliferation, survival, and motility. It’s a type of treatment that’s customized to the specific genetic profile of your cancer.
Reviews
There are no reviews yet.